Updated COVID-19 XBB.1.5 vaccines elicit strong immune responses to new SARS-CoV-2 variants

Two new studies on SARS-CoV-2 vaccine immune responses suggest that the XBB.1.5-containing mRNA vaccines most likely increase protection against COVID-19 caused by currently circulating XBB variants and the emerging BA.2.86 variant in healthy persons and in patients on haemodialysis. The studies build on collaborative work between the Hannover Medical School, Germany and EUROIMMUN and were


Immunoblots: an old friend with a new face – An interview with EUROIMMUN

Immunoblots are an important laboratory-diagnostic tool to detect autoimmune diseases, allergies and infectious diseases. They enable monospecific detection of many different antibodies and, simultaneously, their differentiation. Especially autoimmune diseases, such as myositis, may be caused by manifold antibodies– many of them occurring with very low prevalences. This often leads to a long search and the

Scroll to Top